Catalent Pharma Solutions Signs Agreement With ALK-Abello to Expand Zydis Production Capacity

Catalent Pharma Solutions, Inc and Danish pharmaceutical company ALK-Abelló A/S have signed an agreement that will enable a substantial increase in Zydis oral dissolving tablet production capacity dedicated to ALK-Abelló’s immunotherapy products.
Business Wire